Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 21, 2007; 13(23): 3176-3182
Published online Jun 21, 2007. doi: 10.3748/wjg.v13.i23.3176
Published online Jun 21, 2007. doi: 10.3748/wjg.v13.i23.3176
Table 1 Expression of HIF-2α/EPAS1 in HCC
| Less thanparaneoplastictissue | Equal toparaneoplastictissue | Greater thanparaneoplastictissue | |
| HIF2α/EPAS1 | 9 (4.8%) | 59 (31.6%) | 119 (63.6%) |
Table 2 Correlation of clinicopathologic parameters with HIF-2α/ EPAS1 expression
| HIF-2α/EPAS1 | |||||
| Clinicopathologic parameters | n | Positive | Negative | χ2 | P |
| Age (yr) | |||||
| ≥ 65 | 214 | 143 | 71 | 2.299 | 0.129 |
| < 65 | 101 | 76 | 25 | ||
| Gender | |||||
| Male | 260 | 175 | 85 | 0.452 | 0.063 |
| Female | 55 | 44 | 11 | ||
| Liver cirrhosis | |||||
| Present | 142 | 101 | 41 | 0.314 | 0.576 |
| Absent | 173 | 118 | 55 | ||
| Hepatitis B | |||||
| Present | 212 | 144 | 68 | 0.783 | 0.376 |
| Absent | 103 | 75 | 28 | ||
| Hepatitis C | |||||
| Present | 22 | 17 | 5 | 0.67 | 0.413 |
| Absent | 293 | 202 | 91 | ||
| Child’s classification | |||||
| A | 182 | 129 | 53 | 0.371 | 0.541 |
| B | 133 | 90 | 43 | ||
| Tumor size (cm) | |||||
| ≤ 2 | 62 | 20 | 42 | ||
| 2-5 | 97 | 52 | 45 | 3.417 | 0.065 |
| > 5 | 156 | 147 | 9 | ||
| Tumor capsule | |||||
| Present | 118 | 87 | 31 | 1.575 | 0.21 |
| Absent | 197 | 132 | 65 | ||
| Capsule infiltration | |||||
| Present | 75 | 61 | 14 | 6.479 | 0.011 |
| Absent | 240 | 158 | 82 | ||
| Vascular invasion | |||||
| Present | 73 | 62 | 11 | 10.646 | 0.001 |
| Absent | 242 | 157 | 85 | ||
| Edmondson-Steiner class | |||||
| I | 78 | 29 | 49 | ||
| II | 100 | 53 | 47 | 5.081 | 0.024 |
| III | 137 | 137 | 0 | ||
| Intrahepatic metastasis | |||||
| Present | 97 | 75 | 22 | 4.02 | 0.045 |
| Absent | 218 | 144 | 74 | ||
| Necrosis | |||||
| Present | 108 | 67 | 41 | 4.348 | 0.037 |
| Absent | 207 | 152 | 55 | ||
Table 3 Correlation of HIF-2α/EPAS1 expression with VEGF expression and MVD in HCC
| HIF-2α/EPAS1 expression | ||||
| Parameters | n | Positive | Negative | P |
| VEGF | ||||
| Weak | 56 | 33 | 23 | |
| Moderate | 70 | 40 | 30 | |
| Strong | 114 | 82 | 32 | 0 |
| Negative | 75 | 64 | 11 | |
| MVD | ||||
| Low | 99 | 57 | 42 | |
| Medium | 103 | 71 | 32 | 0.016 |
| High | 113 | 91 | 22 | |
Table 4 Multivariate survival analysis (Cox’s regression)
| Parameters | β | SE | Relative risk | P | 95% CI |
| Tumor size (cm) ( ≤ 2-5 vs≥ 5) | 0.341 | 0.183 | 1.659 | 0.766 | 0.762-0.456 |
| Edmondson-Steiner class (I, II vs III) | 0.157 | 0.095 | 1.17 | 0.91 | 0.986-1.083 |
| Necrosis (no vs yes) | 0.252 | 0.158 | 1.287 | 0.881 | 0.425-5.820 |
| Venous invasion (no vs yes) | 0.079 | 0.13 | 1.521 | 0.001 | 2.564-17.617 |
| Tumor capsule (no vs yes) | 0.366 | 0.149 | 1.269 | 0.633 | 0.824-1.544 |
| Capsule infiltration (no vs yes) | 0.552 | 0.148 | 1.737 | 0.832 | 0.562-5.234 |
| Intrahepatic metastasis (no vs yes) | 0.477 | 0.153 | 1.611 | 0.002 | 1.081-3.872 |
| Child’s class (A vs B) | 0.592 | 0.173 | 1.646 | 0.373 | 0.195-1.873 |
| HIF-2α/EPAS1 (no vs yes) | 1.308 | 0.176 | 3.699 | 0 | 1.385-10.236 |
- Citation: Bangoura G, Liu ZS, Qian Q, Jiang CQ, Yang GF, Jing S. Prognostic significance of HIF-2α/EPAS1 expression in hepatocellular carcinoma. World J Gastroenterol 2007; 13(23): 3176-3182
- URL: https://www.wjgnet.com/1007-9327/full/v13/i23/3176.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i23.3176
